The Analyst Landscape: 7 Takes On United Therapeutics
The Analyst Landscape: 7 Takes On United Therapeutics
分析师领域：7个关于美国联合医疗的见解
The analysis of recent...7 analysts have shared their evaluations of United Therapeutics (NASDAQ:UTHR) during the recent three months, expressing a mix of bullish and bearish perspectives.
在最近三个月内，有7位分析师对美国联合医疗（纳斯达克:UTHR）进行了评估，表达了看好和看淡观点的混合态度。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您将找到他们最近的评级摘要，揭示了过去30天内情绪的变化，并将它们与前几个月进行比较。
Analysts have set 12-month price targets for United Therapeutics, revealing an average target of $409.57, a high estimate of $575.00, and a low estimate of $280.00. Observing a 18.57% increase, the current average has risen from the previous average price target of $345.43.
分析师已为美国联合医疗设定了12个月的价格目标，显示平均目标为409.57美元，高估值为575.00美元，低估值为280.00美元。观察到涨幅为18.57％，当前平均目标已从之前的345.43美元上升。
Breaking Down Analyst Ratings: A Detailed Examination
分析师评级分析：详细分析
The analysis of recent...
最近分析...
登录免费看全文
登录/注册
资讯热榜
更新时间